Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOD1 | Q9Y239 | 9/20 | 0.50 |
| ▸ | GART | P22102 | 3/20 | 0.40 |
| ▸ | GLP1R | P43220 | 7/20 | 0.39 |
| ▸ | SLC6A5 | Q9Y345 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13880487 | 1.00 | NOD1 (0.50) | NOD1GARTGLP1RSLC6A5 | |
| SCHEMBL15896251 | 0.93 | NOD1 (0.50) | NOD1GLP1R | |
| SCHEMBL1688282 | 0.91 | NOD1 (0.40) | NOD1GART | |
| SCHEMBL1688197 | 0.90 | NOD1 (0.50) | NOD1GARTSLC6A5 | |
| SCHEMBL15507494 | 0.89 | NOD1 (0.46) | NOD1GARTSLC6A5 | |
| SCHEMBL12673960 | 0.89 | NOD1 (0.46) | NOD1GARTSLC6A5 | |
| SCHEMBL12673957 | 0.89 | NOD1 (0.46) | NOD1GARTSLC6A5 | |
| SCHEMBL13880488 | 0.88 | GLP1R (0.48) | NOD1GARTGLP1R | |
| SCHEMBL14685782 | 0.88 | GLP1R (0.48) | NOD1GARTGLP1R | |
| SCHEMBL17244040 | 0.87 | GLP1R (0.51) | NOD1GLP1R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20130035285-A1 | NOVEL GLUCAGON ANALOGUES | NOVO NORDISK A/S (DK) | 2013-02-07 | — | — | US | disclosed |
| US-20130035285-A1 | NOVEL GLUCAGON ANALOGUES | NOVO NORDISK A/S (DK) | 2013-02-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130035285-A1 | NOVEL GLUCAGON ANALOGUES | GLP1R, GIPR, IAPP | NOD1 1856/4885GART 865/4885GLP1R 1/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.